Mind Medicine (MindMed) Inc N.MMED.WR

Primary Symbol: MNMD Alternate Symbol(s): N.MMED.WS | N.MMED.WA | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc > Price action

<< Previous

Bullboard Posts

Next >>

Comment by Gilly123on Mar 25, 2021 3:26pm

188 Views

Post# 32877203

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Price action

The fundamentals arent so important for this stock. This is a spec play. Now that some of the euphoria has worn off MMed seems to be trickling down in price. There is no support from where we are now until $2. So without a catalyst it could easily fall to those levels. Potentially it could be a nice bounce target for a pump. Why would I still be interested in a 500million valuation over a billion? What a dumb question. I want cheaper shares closer to fundamental value.

<< Previous

Bullboard Posts

Next >>

Sony’s Alpha 1 II: A new professional photography standard?